The purpose of this proof-of-concept study is to assess the relative safety and feasibility of the SJM Percutaneous Mitral Valve Repair (PMVr) Device.
Subjects will be followed-up through 6 weeks post implantation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
2
A maximum of ten (10) subjects will receive a percutaneous mitral valve clip procedure.
Papworth Hospital
Cambridge, United Kingdom
Device and Procedural Success
The primary objective is to evaluate the technical feasibility and acute device deployment characteristics of the SJM PMVr Device. Technical feasibility and deployment characteristics will be defined as: * The ability of the delivery system to access the mitral valve * The ability of the device to capture mitral valve (MV) leaflet tissue * Ability to plicate MV leaflet tissue * The clip is able to be deployed in MV leaflet tissue * The delivery system is able to be removed.
Time frame: During the investigational procedure
Quantification of SAEs reported that are unique to the investigational procedure
The secondary objective is to evaluate safety of the SJM PMVr device by summarizing SAEs unique to accessing the valve, placing the clip, and removing the delivery system.
Time frame: Through 6 weeks post-implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.